» Articles » PMID: 17329527

Lactation and Changes in Maternal Metabolic Risk Factors

Overview
Journal Obstet Gynecol
Date 2007 Mar 3
PMID 17329527
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the relationship between duration of lactation and changes in maternal metabolic risk factors.

Methods: This 3-year prospective study examined changes in metabolic risk factors among lactating women from preconception to postweaning and among nonlactating women from preconception to postdelivery, in comparison with nongravid women. Of 1,051 (490 black, 561 white) women who attended two consecutive study visits in years 7 (1992-1993) and 10 (1995-1996), 942 were nongravid and 109 had one interim birth. Of parous women, 48 (45%) did not lactate, and 61 (55%) lactated and weaned before year 10. The lactated and weaned women were subdivided by duration of lactation into less than 3 months and 3 months or more. Multiple linear regression models estimated mean 3-year changes in metabolic risk factors adjusted for age, race, parity, education, and behavioral covariates.

Results: Both parous women who did not lactate and parous women who lactated and weaned gained more weight (+5.6, +4.4 kg) and waist girth (+5.3, +4.9 cm) than nongravid women over the 3-year interval; P<.001. Low-density lipoprotein cholesterol (+6.7 mg/dL, P<.05) and fasting insulin (+2.6 microunits, P=.06) increased more for parous women who did not lactate than for nongravid and parous women who lactated and weaned. High-density lipoprotein cholesterol decrements for both parous women who did not lactate and parous women who lactated and weaned were 4.0 mg/dL greater than for nongravid women (P<.001). Among parous, lactated and weaned women, lactation for 3 months or longer was associated with a smaller decrement in high-density lipoprotein cholesterol (-1.3 mg/dL versus -7.3 mg/dL for less than 3 months; P<.01).

Conclusion: Lactation may attenuate unfavorable metabolic risk factor changes that occur with pregnancy, with effects apparent after weaning. As a modifiable behavior, lactation may affect women's future risk of cardiovascular and metabolic diseases.

Level Of Evidence: II.

Citing Articles

The Impact of Maternal Chronic Inflammatory Conditions on Breast Milk Composition: Possible Influence on Offspring Metabolic Programming.

Arenas G, Barrera M, Contreras-Duarte S Nutrients. 2025; 17(3).

PMID: 39940245 PMC: 11820913. DOI: 10.3390/nu17030387.


Early Postpartum Metabolic Heterogeneity Among Women Who Progressed to Type 2 Diabetes After Gestational Diabetes: A Prospective Cohort.

Khan S, Van J, Xiangyu Z, Alexeeff S, Razani B, Wheeler M Diabetes Metab Res Rev. 2025; 41(1):e70027.

PMID: 39810724 PMC: 11733828. DOI: 10.1002/dmrr.70027.


Lipid signature changes of women with gestational diabetes mellitus in response to puerperal exclusive breastfeeding.

He J, Yin X, Yu T, Li L, Cui Y, Jiang C J Diabetes Investig. 2024; 16(2):315-325.

PMID: 39565018 PMC: 11786177. DOI: 10.1111/jdi.14349.


Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review.

Zimodro J, Mucha M, Berthold H, Gouni-Berthold I Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065763 PMC: 11279947. DOI: 10.3390/ph17070913.


Association between breastfeeding duration and diabetes mellitus in menopausal women: a machine-learning analysis using population-based retrospective study.

Choi E, Lee J, Lee H, Lee K, Ahn K Int Breastfeed J. 2024; 19(1):33.

PMID: 38745339 PMC: 11092012. DOI: 10.1186/s13006-024-00642-z.


References
1.
Qureshi I, Xi X, Limbu Y, Bin H, Chen M . Hyperlipidaemia during normal pregnancy, parturition and lactation. Ann Acad Med Singap. 1999; 28(2):217-21. View

2.
Manson J, Rimm E, Colditz G, Stampfer M, Willett W, Arky R . Parity and incidence of non-insulin-dependent diabetes mellitus. Am J Med. 1992; 93(1):13-8. DOI: 10.1016/0002-9343(92)90674-z. View

3.
Kritz-Silverstein D, Barrett-Connor E, Wingard D, Friedlander N . Relation of pregnancy history to insulin levels in older, nondiabetic women. Am J Epidemiol. 1994; 140(4):375-82. DOI: 10.1093/oxfordjournals.aje.a117260. View

4.
Gotto Jr A . High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease. Am Heart J. 2002; 144(6 Suppl):S33-42. DOI: 10.1067/mhj.2002.130301. View

5.
Smith D, Lewis C, Caveny J, Perkins L, Burke G, Bild D . Longitudinal changes in adiposity associated with pregnancy. The CARDIA Study. Coronary Artery Risk Development in Young Adults Study. JAMA. 1994; 271(22):1747-51. View